Natural Killer Cells Therapeutics Market Report

Global and China Natural Killer Cells Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 10, 2022
  • PAGES：141
  • REPORT CODE：GMM1451377
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Natural Killer Cells Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Nantkwest

    • Nkarta Therapeutics

    • Glycostem Therapeutics

    • Ziopharm Oncology

    • Affimed

    • Celgene Corporation

    • Fate Therapeutics

    • Fortress Biotech

    • Innate Pharma

    • NKT Therapeutics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • NK Cell Therapies

    • NK Cell Directed Antibodies

    Application:

    • Research Centers & Institutes

    • Hospitals

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Natural Killer Cells Therapeutics Industry Overview

      • 1.1.1 Natural Killer Cells Therapeutics Market Scope and Market Segments

      • 1.1.2 Natural Killer Cells Therapeutics Industry Characteristics

      • 1.1.3 Global and China Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Natural Killer Cells Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Natural Killer Cells Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 NK Cell Therapies

      • 1.2.2 NK Cell Directed Antibodies

    • 1.3 Global Natural Killer Cells Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Research Centers & Institutes

      • 1.3.2 Hospitals

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Natural Killer Cells Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Natural Killer Cells Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Natural Killer Cells Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Natural Killer Cells Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Natural Killer Cells Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Natural Killer Cells Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Natural Killer Cells Therapeutics Industry PEST Analysis

    • 2.3 Natural Killer Cells Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Natural Killer Cells Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Natural Killer Cells Therapeutics Industry

    Chapter 3 Global and China Natural Killer Cells Therapeutics Market, by Manufacturer

    • 3.1 Global and China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Natural Killer Cells Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Natural Killer Cells Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Natural Killer Cells Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Natural Killer Cells Therapeutics Market Top 3 Players

    Chapter 4 Global and China Natural Killer Cells Therapeutics Market, by Type (2017-2028)

    • 4.1 Natural Killer Cells Therapeutics Market Trend, by Type

    • 4.2 Global Natural Killer Cells Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Natural Killer Cells Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Natural Killer Cells Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Natural Killer Cells Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Natural Killer Cells Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Natural Killer Cells Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Natural Killer Cells Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Natural Killer Cells Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Natural Killer Cells Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Natural Killer Cells Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Natural Killer Cells Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Natural Killer Cells Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Natural Killer Cells Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Natural Killer Cells Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Natural Killer Cells Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Natural Killer Cells Therapeutics Market Analysis

    • 7.1 North America Natural Killer Cells Therapeutics Market, by Type

    • 7.2 North America Natural Killer Cells Therapeutics Market, by Application

    • 7.3 North America Natural Killer Cells Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Natural Killer Cells Therapeutics Market Analysis

    • 8.1 Europe Natural Killer Cells Therapeutics Market, by Type

    • 8.2 Europe Natural Killer Cells Therapeutics Market, by Application

    • 8.3 Europe Natural Killer Cells Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Natural Killer Cells Therapeutics Market Analysis

    • 9.1 APAC Natural Killer Cells Therapeutics Market, by Type

    • 9.2 APAC Natural Killer Cells Therapeutics Market, by Application

    • 9.3 APAC Natural Killer Cells Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Natural Killer Cells Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Natural Killer Cells Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Natural Killer Cells Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Natural Killer Cells Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Natural Killer Cells Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Natural Killer Cells Therapeutics Company Profiles

      • 11.1 Nantkwest

        • 11.1.1 Nantkwest Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Nantkwest Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Nantkwest Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Nkarta Therapeutics

        • 11.2.1 Nkarta Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Nkarta Therapeutics Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Glycostem Therapeutics

        • 11.3.1 Glycostem Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Glycostem Therapeutics Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Ziopharm Oncology

        • 11.4.1 Ziopharm Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Ziopharm Oncology Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Ziopharm Oncology Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Affimed

        • 11.5.1 Affimed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Affimed Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Affimed Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Celgene Corporation

        • 11.6.1 Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Celgene Corporation Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Celgene Corporation Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Fate Therapeutics

        • 11.7.1 Fate Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Fate Therapeutics Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Fate Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Fortress Biotech

        • 11.8.1 Fortress Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Fortress Biotech Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Fortress Biotech Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Innate Pharma

        • 11.9.1 Innate Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Innate Pharma Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Innate Pharma Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 NKT Therapeutics

        • 11.10.1 NKT Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 NKT Therapeutics Natural Killer Cells Therapeutics Product Profiles, Application and Specification

        • 11.10.3 NKT Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Natural Killer Cells Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Natural Killer Cells Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Natural Killer Cells Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate of NK Cell Therapies (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate of NK Cell Directed Antibodies (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate of Research Centers & Institutes (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Natural Killer Cells Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Natural Killer Cells Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Natural Killer Cells Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Natural Killer Cells Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Natural Killer Cells Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Natural Killer Cells Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Price Trend, by Type (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Value, by Type (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Natural Killer Cells Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Natural Killer Cells Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Value, by Application (2017-2028)

    • Table China Natural Killer Cells Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Natural Killer Cells Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Natural Killer Cells Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Natural Killer Cells Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Natural Killer Cells Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Natural Killer Cells Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Natural Killer Cells Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Natural Killer Cells Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cells Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer Cells Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cells Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer Cells Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Natural Killer Cells Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Natural Killer Cells Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Nantkwest Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nantkwest Product Profiles, Application and Specification

    • Table Nantkwest Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nkarta Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nkarta Therapeutics Product Profiles, Application and Specification

    • Table Nkarta Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Glycostem Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Glycostem Therapeutics Product Profiles, Application and Specification

    • Table Glycostem Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ziopharm Oncology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ziopharm Oncology Product Profiles, Application and Specification

    • Table Ziopharm Oncology Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Affimed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Affimed Product Profiles, Application and Specification

    • Table Affimed Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Corporation Product Profiles, Application and Specification

    • Table Celgene Corporation Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fate Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fate Therapeutics Product Profiles, Application and Specification

    • Table Fate Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fortress Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fortress Biotech Product Profiles, Application and Specification

    • Table Fortress Biotech Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Innate Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Innate Pharma Product Profiles, Application and Specification

    • Table Innate Pharma Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NKT Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NKT Therapeutics Product Profiles, Application and Specification

    • Table NKT Therapeutics Natural Killer Cells Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US